Hytrin: Effective Blood Pressure and BPH Symptom Control
| Product dosage: 1mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.82 | $49.02 (0%) | 🛒 Add to cart |
| 90 | $0.74 | $73.53 $66.22 (10%) | 🛒 Add to cart |
| 120 | $0.70 | $98.04 $84.28 (14%) | 🛒 Add to cart |
| 180 | $0.65 | $147.06 $117.82 (20%) | 🛒 Add to cart |
| 270 | $0.63 | $220.59 $170.28 (23%) | 🛒 Add to cart |
| 360 | $0.62
Best per pill | $294.12 $223.60 (24%) | 🛒 Add to cart |
| Product dosage: 2mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.09 | $62.78 (0%) | 🛒 Add to cart |
| 60 | $1.63 | $125.56 $98.04 (22%) | 🛒 Add to cart |
| 90 | $1.48 | $188.34 $133.30 (29%) | 🛒 Add to cart |
| 120 | $1.40 | $251.12 $168.56 (33%) | 🛒 Add to cart |
| 180 | $1.33 | $376.68 $239.08 (37%) | 🛒 Add to cart |
| 270 | $1.28
Best per pill | $565.02 $346.58 (39%) | 🛒 Add to cart |
| Product dosage: 5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.55 | $76.54 (0%) | 🛒 Add to cart |
| 60 | $1.92 | $153.08 $115.24 (25%) | 🛒 Add to cart |
| 90 | $1.71 | $229.62 $153.94 (33%) | 🛒 Add to cart |
| 120 | $1.61 | $306.16 $193.50 (37%) | 🛒 Add to cart |
| 180 | $1.50 | $459.24 $270.90 (41%) | 🛒 Add to cart |
| 270 | $1.44
Best per pill | $688.86 $387.86 (44%) | 🛒 Add to cart |
Synonyms
| |||
Hytrin (terazosin hydrochloride) is a selective alpha-1 adrenergic receptor blocker prescribed for the management of hypertension (high blood pressure) and the symptomatic treatment of benign prostatic hyperplasia (BPH). As a quinazoline derivative, it works by relaxing vascular smooth muscle and dilating peripheral vessels, thereby reducing blood pressure, and by relaxing smooth muscle in the prostate and bladder neck, improving urinary flow in men with an enlarged prostate. Its dual-action mechanism and well-established efficacy profile make it a trusted choice among healthcare providers for long-term cardiovascular and urological management.
Features
- Active Pharmaceutical Ingredient: Terazosin hydrochloride.
- Available Dosage Forms: Oral tablets (1 mg, 2 mg, 5 mg, 10 mg).
- Pharmacological Class: Selective antagonist of postsynaptic alpha-1 adrenergic receptors.
- Mechanism of Action: Causes vasodilation (reducing peripheral vascular resistance) and relaxation of smooth muscle in the prostate and bladder neck.
- Bioavailability: Approximately 90% following oral administration.
- Half-life: ~12 hours, supporting a convenient once-daily dosing regimen.
- Metabolism: Extensively metabolized in the liver, with minimal excretion of unchanged drug.
Benefits
- Effective Blood Pressure Reduction: Lowers both systolic and diastolic blood pressure, helping to reduce the long-term risk of stroke, heart attack, and kidney damage associated with hypertension.
- Significant Improvement in Urinary Symptoms: Provides relief from BPH symptoms such as weak stream, hesitancy, dribbling, and nocturia (frequent urination at night), improving overall quality of life.
- Convenient Dosing: The long half-life allows for a simple once-daily administration, improving patient adherence to the treatment regimen.
- Dual Therapeutic Indication: Offers a treatment solution for two common conditions, which can be particularly beneficial for patients presenting with both hypertension and BPH.
- Well-Established Safety Profile: Decades of clinical use and research have solidified its efficacy and safety parameters when used as directed.
Common use
Hytrin is primarily indicated for two conditions. First, it is used in the management of hypertension, either as monotherapy or in combination with other antihypertensive agents like diuretics or beta-blockers. Second, it is approved for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). It is not intended for use in women or children. For BPH, it is important to note that Hytrin treats the symptoms of an enlarged prostate but does not reduce the size of the prostate itself. A proper diagnostic workup is necessary to confirm BPH and rule out prostate cancer before initiating treatment.
Dosage and direction
Dosage must be individualized based on the patient’s blood pressure response or symptomatic improvement in BPH.
- For Hypertension: The initial dose is 1 mg at bedtime. This initial dosing schedule is mandatory to minimize the risk of a sudden drop in blood pressure (first-dose effect). The dose can be slowly titrated upward to achieve the desired blood pressure response. Common maintenance doses range from 1 mg to 5 mg administered once daily, though some patients may benefit from up to 20 mg per day. Doses may be divided if necessary.
- For Benign Prostatic Hyperplasia (BPH): The initial dose is also 1 mg at bedtime. The dose should be increased in a step-wise fashion to 2 mg, 5 mg, or 10 mg once daily to achieve the desired improvement in symptoms and flow rate. The recommended maintenance dose is 10 mg once daily. If no response is achieved after 4–6 weeks of 10 mg daily, re-evaluation is recommended.
- Administration: The tablet can be taken with or without food. It should be swallowed whole with a glass of water.
Precautions
- First-Dose Effect: A sudden and significant drop in blood pressure, accompanied by dizziness or fainting (syncope), can occur within 30 to 90 minutes after the very first dose or any subsequent dose increase. This risk is minimized by initiating therapy at the 1 mg dose and taking it at bedtime. Patients should avoid driving or operating machinery for 12 hours after the first dose.
- Orthostatic Hypotension: Dizziness, lightheadedness, or fainting can occur when standing up quickly from a sitting or lying position due to a drop in blood pressure. Patients should rise slowly and carefully.
- Intraoperative Floppy Iris Syndrome (IFIS): This alpha-1 blocker class effect has been observed during cataract surgery. Patients considering cataract surgery must inform their ophthalmologist that they are taking or have previously taken Hytrin.
- Drowsiness/Somnolence: Patients should exercise caution when driving, operating machinery, or performing hazardous tasks, as the drug can cause drowsiness or blurred vision.
- Regular Monitoring: Blood pressure and BPH symptoms should be monitored regularly by a physician to assess the therapeutic response and need for continued therapy.
Contraindications
Hytrin is contraindicated in patients with a known hypersensitivity to terazosin hydrochloride, any other quinazolines (e.g., doxazosin, prazosin), or any of the inactive ingredients in the formulation.
Possible side effect
Like all medications, Hytrin can cause side effects, although not everybody gets them. Common side effects are often related to its pharmacological action (vasodilation) and are usually most pronounced after initiation of therapy or a dose increase.
- Very Common (≥10%): Dizziness, headache, asthenia (lack of energy).
- Common (1-10%): Postural dizziness, palpitations, nausea, peripheral edema (swelling, particularly in the feet and ankles), somnolence (drowsiness), nasal congestion, blurred vision, vertigo.
- Uncommon (0.1-1%): Syncope (fainting), weight gain, urinary incontinence, priapism (a prolonged and painful erection—requires immediate medical attention).
- Other reported side effects include dyspnea (shortness of breath), tachycardia (rapid heart rate), and gastrointestinal discomfort.
Drug interaction
Concomitant use of Hytrin with other drugs that lower blood pressure can potentiate this effect and increase the risk of hypotension, dizziness, and syncope. Caution is advised with:
- Other antihypertensives (e.g., beta-blockers, ACE inhibitors, calcium channel blockers, diuretics).
- Phosphodiesterase-5 (PDE5) inhibitors (e.g., sildenafil, tadalafil, vardenafil) used for erectile dysfunction, due to additive blood-pressure-lowering effects.
- Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, ritonavir) may increase terazosin plasma concentrations.
- Non-steroidal Anti-inflammatory Drugs (NSAIDs) (e.g., ibuprofen, naproxen) may reduce the antihypertensive effect of terazosin.
- Estrogens may also reduce the antihypertensive effect. Patients must inform their doctor of all prescription, non-prescription, and herbal products they are taking.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. If it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed. Patients should never take a double dose to make up for a forgotten one.
Overdose
An overdose would be expected to manifest as exaggerated pharmacological effects, primarily severe hypotension (profound dizziness, drowsiness, fainting). In the event of a suspected overdose, immediate medical attention must be sought. Supportive care is the mainstay of treatment, which may include placing the patient in a supine position, administering IV fluids, and using vasopressor agents to restore blood pressure if necessary. Gastric lavage or activated charcoal may be considered if ingestion was very recent.
Storage
- Store at room temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F).
- Protect from light and moisture.
- Keep in the original container, tightly closed.
- Keep all medications out of the sight and reach of children and pets.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here.
Reviews
- “As a cardiologist with over 20 years of practice, I find Hytrin to be a reliable and effective option for alpha-blocker therapy, particularly in male hypertensive patients who also present with BPH. The titration protocol is key to managing the first-dose effect.” – Dr. A. Reynolds, MD
- “After starting my father on Hytrin for his BPH, he reported a significant improvement in urinary flow within a few weeks. The nighttime trips to the bathroom reduced dramatically, greatly improving his sleep and overall well-being. The initial dizziness was mild and passed quickly.” – John D. (Caregiver)
- “Clinical trial data consistently supports the efficacy of terazosin in reducing both standing and supine blood pressure. Its long half-life is a distinct advantage for patient compliance over shorter-acting agents in its class.” – Clinical Pharmacologist Review
- “The 10 mg maintenance dose has managed my hypertension effectively for years with minimal side effects. I appreciate the once-daily convenience.” – Patient with long-term hypertension